Click Here to return To Results

 

Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004 See this aricle in Pubmed Article Abstract Intravenous immunoglobulin treatment for the first year from onset of the first neurological event suggestive of demyelinative disease significantly lowers the incidence of a second attack and reduces disease reactivity as measured by brain magnetic resonance imaging.

Related Tags

(click to filter results - removes previous filter) gammaglobulin therapy,intravenous MRI MRI,serial multiple sclerosis multiple sclerosis,treatment of multiple sclerosis,treatment of,first attack treatment of neurologic disorder

Click Here to return To Results